Soluble urokinase plasminogen activation receptor (suPAR) is an emerging fresh biomarker, which includes been shown never to just correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. procalcitonin. Alternatively, the prognostic value of suPAR among ill patients is inconclusive critically. In these research by Koch et al., suPAR amounts correlated with disease intensity… Continue reading Soluble urokinase plasminogen activation receptor (suPAR) is an emerging fresh biomarker,